Bluejay Diagnostics BJDX Stock
Bluejay Diagnostics Price Chart
Bluejay Diagnostics BJDX Financial and Trading Overview
| Bluejay Diagnostics stock price | 0.84 USD |
| Previous Close | 0.84 USD |
| Open | 0.85 USD |
| Bid | 0.6 USD x 200 |
| Ask | 1.1 USD x 200 |
| Day's Range | 0.83 - 0.85 USD |
| 52 Week Range | 0.8 - 16.68 USD |
| Volume | 112.93K USD |
| Avg. Volume | 5.57M USD |
| Market Cap | 865.64K USD |
| Beta (5Y Monthly) | 0.907 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.27 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BJDX Valuation Measures
| Enterprise Value | -5780274 USD |
| Trailing P/E | N/A |
| Forward P/E | -2.614375 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.17627476 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.799 |
Trading Information
Bluejay Diagnostics Stock Price History
| Beta (5Y Monthly) | 0.907 |
| 52-Week Change | -86.50% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 16.68 USD |
| 52 Week Low | 0.8 USD |
| 50-Day Moving Average | 0.95 USD |
| 200-Day Moving Average | 2.07 USD |
BJDX Share Statistics
| Avg. Volume (3 month) | 5.57M USD |
| Avg. Daily Volume (10-Days) | 704.02K USD |
| Shares Outstanding | 1.03M |
| Float | 4.38M |
| Short Ratio | 0.04 |
| % Held by Insiders | 2.03% |
| % Held by Institutions | 9.78% |
| Shares Short | 131.48K |
| Short % of Float | 13.53% |
| Short % of Shares Outstanding | 12.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.083% |
| Return on Equity (ttm) | -98.88% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7236399 USD |
| Net Income Avi to Common (ttm) | -7270698 USD |
| Diluted EPS (ttm) | -2.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.6M USD |
| Total Cash Per Share (mrq) | 2.15 USD |
| Total Debt (mrq) | 80.67K USD |
| Total Debt/Equity (mrq) | 0.86 USD |
| Current Ratio (mrq) | 4.637 |
| Book Value Per Share (mrq) | 4.746 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5903219 USD |
| Levered Free Cash Flow (ttm) | -3545295 USD |
Profile of Bluejay Diagnostics
| Country | United States |
| State | MA |
| City | Acton |
| Address | 360 Massachusetts Avenue |
| ZIP | 01720 |
| Phone | 844 327 7078 |
| Website | https://bluejaydx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Q&A For Bluejay Diagnostics Stock
What is a current BJDX stock price?
Bluejay Diagnostics BJDX stock price today per share is 0.84 USD.
How to purchase Bluejay Diagnostics stock?
You can buy BJDX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bluejay Diagnostics?
The stock symbol or ticker of Bluejay Diagnostics is BJDX.
Which industry does the Bluejay Diagnostics company belong to?
The Bluejay Diagnostics industry is Medical Devices.
How many shares does Bluejay Diagnostics have in circulation?
The max supply of Bluejay Diagnostics shares is 1.03M.
What is Bluejay Diagnostics Price to Earnings Ratio (PE Ratio)?
Bluejay Diagnostics PE Ratio is now.
What was Bluejay Diagnostics earnings per share over the trailing 12 months (TTM)?
Bluejay Diagnostics EPS is -2.27 USD over the trailing 12 months.
Which sector does the Bluejay Diagnostics company belong to?
The Bluejay Diagnostics sector is Healthcare.
Bluejay Diagnostics BJDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27190.86 USD — |
+1.19
|
6.86B USD — | 27112.24 USD — | 27353.68 USD — | — - | 6.86B USD — |
|
US Tech Health Care
IXHC
US
|
1302.61 USD — |
-0.29
|
— — | 1298.55 USD — | 1311.62 USD — | — - | — — |
- {{ link.label }} {{link}}
